1500 related articles for article (PubMed ID: 33711754)
21. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
22. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis.
Malas MB; Naazie IN; Elsayed N; Mathlouthi A; Marmor R; Clary B
EClinicalMedicine; 2020 Dec; 29():100639. PubMed ID: 33251499
[TBL] [Abstract][Full Text] [Related]
23. Variations across Europe in hospitalization and management of pregnant women with SARS-CoV-2 during the initial phase of the pandemic: Multi-national population-based cohort study using the International Network of Obstetric Survey Systems (INOSS).
de Bruin O; Engjom H; Vousden N; Ramakrishnan R; Aabakke AJM; Äyräs O; Donati S; Jónasdóttir E; Knight M; Overtoom EM; Salvatore MA; Sturkenboom MCJM; Svanvik T; Varpula R; Vercoutere A; Bloemenkamp KWM;
Acta Obstet Gynecol Scand; 2023 Nov; 102(11):1521-1530. PubMed ID: 37594175
[TBL] [Abstract][Full Text] [Related]
24. A cohort study of patients hospitalised with SARS-CoV-2 infection in Ontario: patient characteristics and outcomes by wave.
Habbous S; Lambrinos A; Ming K; Hellsten E
Swiss Med Wkly; 2024 Mar; 154():3636. PubMed ID: 38579312
[TBL] [Abstract][Full Text] [Related]
25. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
26. Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes.
Hammami R; Jdidi J; Chakroun O; Issaoui F; Ktata N; Maamri H; Baklouti M; Bahloul A; Gargouri R; Nasri A; Msaad S; Kammoun S; Kammoun S; Rejab IB; Charfeddine S; Abid L
PLoS One; 2022; 17(8):e0270195. PubMed ID: 35925930
[TBL] [Abstract][Full Text] [Related]
27. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
[TBL] [Abstract][Full Text] [Related]
28. Low rates of venous thromboembolism in hospitalised COVID-19 patients: an Australian experience.
Ong J; Walker P; Singh KP; Bishop E; Htun K
Intern Med J; 2022 Jan; 52(1):37-41. PubMed ID: 34524710
[TBL] [Abstract][Full Text] [Related]
29. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
30. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
31. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
32. Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
Nafilyan V; Islam N; Mathur R; Ayoubkhani D; Banerjee A; Glickman M; Humberstone B; Diamond I; Khunti K
Eur J Epidemiol; 2021 Jun; 36(6):605-617. PubMed ID: 34132940
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward.
Avruscio G; Camporese G; Campello E; Bernardi E; Persona P; Passarella C; Noventa F; Cola M; Navalesi P; Cattelan A; Tiberio I; Boscolo A; Spiezia L; Simioni P;
Clin Transl Sci; 2020 Nov; 13(6):1108-1114. PubMed ID: 32989908
[TBL] [Abstract][Full Text] [Related]
34. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study.
Uka A; Buettcher M; Bernhard-Stirnemann S; Fougère Y; Moussaoui D; Kottanattu L; Wagner N; Zimmermann P; Ritz N;
Eur J Pediatr; 2022 Mar; 181(3):1245-1255. PubMed ID: 34845526
[TBL] [Abstract][Full Text] [Related]
36. Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area.
Sapey E; Gallier S; Mainey C; Nightingale P; McNulty D; Crothers H; Evison F; Reeves K; Pagano D; Denniston AK; Nirantharakumar K; Diggle P; Ball S;
BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32873607
[TBL] [Abstract][Full Text] [Related]
37. GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study.
Whittaker HR; Gulea C; Koteci A; Kallis C; Morgan AD; Iwundu C; Weeks M; Gupta R; Quint JK
BMJ; 2021 Dec; 375():e065834. PubMed ID: 34965929
[TBL] [Abstract][Full Text] [Related]
38. An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients.
Jonmarker S; Litorell J; Dahlberg M; Stackelberg O; Everhov ÅH; Söderberg M; Rubenson-Wahlin R; Günther M; Mårtensson J; Hollenberg J; Joelsson-Alm E; Cronhjort M
Acta Anaesthesiol Scand; 2022 Mar; 66(3):365-374. PubMed ID: 34875111
[TBL] [Abstract][Full Text] [Related]
39. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]